MRGPRX2 inhibitors(Enanta Pharmaceuticals Inc)

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameMRGPRX2 inhibitors(Enanta Pharmaceuticals Inc)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMRGPRX2 inhibitors
TargetsMRGPRX2
Therapy Area/IndicationsPrurigo NodularisChronic UrticariaAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisChronic UrticariaAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A